FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087058708> ?p ?o ?g. }

• W2087058708 endingPage "1235" @default.
• W2087058708 startingPage "1224" @default.
• W2087058708 abstract "BackgroundDetection of epidermal growth factor receptor (EGFR) mutations in advanced non-small cell lung cancer (NSCLC) patients has relied on DNA purification from biopsies, amplification, and sequencing. However, the number of tumor cells in a sample is often insufficient for EGFR assessment.MethodsWe prospectively screened 1380 NSCLC patients for EGFR mutations but found that 268 were not evaluable because of insufficient tumor tissue. We therefore developed and validated a method of detecting EGFR mutations in these samples. Tumor cells were microdissected into polymerase chain reaction buffer and amplified. EGFR mutations were detected by length analysis of fluorescently labeled polymerase chain reaction products and TaqMan assay.ResultsWe determined EGFR status in 217 (81%) of the 268 primary NSCLC samples not evaluable in our original study—fresh and paraffin-embedded with less than 150 cells. Exon 19 deletions were detected in 11.5% of patients and exon 21 L858R mutations in 5.5%. In addition, the exon 20 T790M mutation was detected in 6 of 15 (40%) patients at the time of progression to erlotinib. The primary, sensitive mutation was present in all tumor cells, whereas the T790M mutation was absent in some groups.ConclusionsThe method presented here eliminates the need for DNA purification and allows for detection of EGFR mutations in samples containing as few as eight cancer cells. Detection of epidermal growth factor receptor (EGFR) mutations in advanced non-small cell lung cancer (NSCLC) patients has relied on DNA purification from biopsies, amplification, and sequencing. However, the number of tumor cells in a sample is often insufficient for EGFR assessment. We prospectively screened 1380 NSCLC patients for EGFR mutations but found that 268 were not evaluable because of insufficient tumor tissue. We therefore developed and validated a method of detecting EGFR mutations in these samples. Tumor cells were microdissected into polymerase chain reaction buffer and amplified. EGFR mutations were detected by length analysis of fluorescently labeled polymerase chain reaction products and TaqMan assay. We determined EGFR status in 217 (81%) of the 268 primary NSCLC samples not evaluable in our original study—fresh and paraffin-embedded with less than 150 cells. Exon 19 deletions were detected in 11.5% of patients and exon 21 L858R mutations in 5.5%. In addition, the exon 20 T790M mutation was detected in 6 of 15 (40%) patients at the time of progression to erlotinib. The primary, sensitive mutation was present in all tumor cells, whereas the T790M mutation was absent in some groups. The method presented here eliminates the need for DNA purification and allows for detection of EGFR mutations in samples containing as few as eight cancer cells." @default.
• W2087058708 created "2016-06-24" @default.
• W2087058708 creator A5001587695 @default.
• W2087058708 creator A5026583435 @default.
• W2087058708 creator A5029444262 @default.
• W2087058708 creator A5030827550 @default.
• W2087058708 creator A5037578500 @default.
• W2087058708 creator A5039171238 @default.
• W2087058708 creator A5042261240 @default.
• W2087058708 creator A5044887899 @default.
• W2087058708 creator A5050077227 @default.
• W2087058708 creator A5055118551 @default.
• W2087058708 creator A5056676096 @default.
• W2087058708 creator A5077762927 @default.
• W2087058708 creator A5079395858 @default.
• W2087058708 creator A5081008083 @default.
• W2087058708 creator A5084391772 @default.
• W2087058708 creator A5087391532 @default.
• W2087058708 creator A5090871578 @default.
• W2087058708 date "2008-11-01" @default.
• W2087058708 modified "2023-10-18" @default.
• W2087058708 title "A Sensitive Method for Detecting EGFR Mutations in Non-small Cell Lung Cancer Samples with Few Tumor Cells" @default.
• W2087058708 cites W1569610737 @default.
• W2087058708 cites W1979332174 @default.
• W2087058708 cites W1991481804 @default.
• W2087058708 cites W1996405911 @default.
• W2087058708 cites W2001829888 @default.
• W2087058708 cites W2002937040 @default.
• W2087058708 cites W2003984225 @default.
• W2087058708 cites W2014187999 @default.
• W2087058708 cites W2016710415 @default.
• W2087058708 cites W2021312892 @default.
• W2087058708 cites W2037355469 @default.
• W2087058708 cites W2037873277 @default.
• W2087058708 cites W2043696829 @default.
• W2087058708 cites W2048538776 @default.
• W2087058708 cites W2068244265 @default.
• W2087058708 cites W2086834163 @default.
• W2087058708 cites W2091623835 @default.
• W2087058708 cites W2096786080 @default.
• W2087058708 cites W2098379595 @default.
• W2087058708 cites W2106297623 @default.
• W2087058708 cites W2109361793 @default.
• W2087058708 cites W2111109297 @default.
• W2087058708 cites W2114642822 @default.
• W2087058708 cites W2130601380 @default.
• W2087058708 cites W2132392721 @default.
• W2087058708 cites W2136263263 @default.
• W2087058708 cites W2138312420 @default.
• W2087058708 cites W2139236349 @default.
• W2087058708 cites W2140775102 @default.
• W2087058708 cites W2143877481 @default.
• W2087058708 cites W2145497412 @default.
• W2087058708 cites W2161821474 @default.
• W2087058708 cites W2167010023 @default.
• W2087058708 cites W2168554121 @default.
• W2087058708 cites W2169816570 @default.
• W2087058708 doi "https://doi.org/10.1097/jto.0b013e318189f579" @default.
• W2087058708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18978556" @default.
• W2087058708 hasPublicationYear "2008" @default.
• W2087058708 type Work @default.
• W2087058708 sameAs 2087058708 @default.
• W2087058708 citedByCount "105" @default.
• W2087058708 countsByYear W20870587082012 @default.
• W2087058708 countsByYear W20870587082013 @default.
• W2087058708 countsByYear W20870587082014 @default.
• W2087058708 countsByYear W20870587082015 @default.
• W2087058708 countsByYear W20870587082017 @default.
• W2087058708 countsByYear W20870587082018 @default.
• W2087058708 countsByYear W20870587082020 @default.
• W2087058708 countsByYear W20870587082021 @default.
• W2087058708 countsByYear W20870587082022 @default.
• W2087058708 crossrefType "journal-article" @default.
• W2087058708 hasAuthorship W2087058708A5001587695 @default.
• W2087058708 hasAuthorship W2087058708A5026583435 @default.
• W2087058708 hasAuthorship W2087058708A5029444262 @default.
• W2087058708 hasAuthorship W2087058708A5030827550 @default.
• W2087058708 hasAuthorship W2087058708A5037578500 @default.
• W2087058708 hasAuthorship W2087058708A5039171238 @default.
• W2087058708 hasAuthorship W2087058708A5042261240 @default.
• W2087058708 hasAuthorship W2087058708A5044887899 @default.
• W2087058708 hasAuthorship W2087058708A5050077227 @default.
• W2087058708 hasAuthorship W2087058708A5055118551 @default.
• W2087058708 hasAuthorship W2087058708A5056676096 @default.
• W2087058708 hasAuthorship W2087058708A5077762927 @default.
• W2087058708 hasAuthorship W2087058708A5079395858 @default.
• W2087058708 hasAuthorship W2087058708A5081008083 @default.
• W2087058708 hasAuthorship W2087058708A5084391772 @default.
• W2087058708 hasAuthorship W2087058708A5087391532 @default.
• W2087058708 hasAuthorship W2087058708A5090871578 @default.
• W2087058708 hasBestOaLocation W20870587081 @default.
• W2087058708 hasConcept C104317684 @default.
• W2087058708 hasConcept C121608353 @default.
• W2087058708 hasConcept C126322002 @default.
• W2087058708 hasConcept C142724271 @default.
• W2087058708 hasConcept C143660080 @default.
• W2087058708 hasConcept C153911025 @default.
• W2087058708 hasConcept C176944494 @default.

• next